Medable

Medable, Inc is a technology company based in Palo Alto, California, that specializes in cloud-based software platforms for clinical trials, particularly decentralized clinical trial (DCT) solutions. Founded in 2015 by Dr. Michelle Longmire and her team, Medable's mission is to enhance the delivery of effective therapies to patients by addressing traditional challenges in clinical research. The company offers a range of digital tools designed to improve clinical trial execution, patient engagement, and data collection. Key offerings include a comprehensive DCT platform that streamlines trial design and data quality, eCOA+ for efficient clinical outcome data capture, and digital tools for remote patient consent management. Medable also provides a platform for rapid study creation and launch, along with features like cloud-agnostic APIs and multi-study participant apps. Medable primarily serves pharmaceutical companies, biopharma firms, and contract research organizations, focusing on various therapeutic areas such as oncology and vaccines. Operating on a Software-as-a-Service (SaaS) model, Medable has experienced significant growth, ranking among the fastest-growing private companies in the U.S.